Permanently Discontinued

ZERIT - CAP 20MG

BRISTOL-MYERS SQUIBB CANADA

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is ZERIT - CAP 20MG discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that ZERIT - CAP 20MG has been permanently discontinued (last updated April 1, 2020). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is ZERIT - CAP 20MG not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Check with your pharmacist

StatusPermanently Discontinued

Same-ingredient products on fileNone found

Affected strength20MG

Report last updated2020-04-01

Checked by MedShort2026-11-12

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02216094

Strength

20MG

Dosage Form

CAPSULE

Route

ORAL

Active Ingredient

STAVUDINE

See all STAVUDINE products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

2020-04-01

Permanently Discontinued

Business reasons

Other Products from BRISTOL-MYERS SQUIBB CANADA

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ABRAXANE FOR INJECTABLE SUSPENSION

100MG · DIN 02281066

BARACLUDE

0.5MG · DIN 02282224

BREYANZI

120000000CELLS · DIN 02527138

CAMZYOS

15MG · DIN 02532573

CAMZYOS

5MG · DIN 02532557

CAMZYOS

2.5MG · DIN 02532549